FDA Inspection 558850 — Carter BloodCare - Texoma

Carter BloodCare - Texoma — FEI 1676462

The FDA completed an inspection of Carter BloodCare - Texoma on January 21, 2009 in Sherman, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 21, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sherman, TX (United States)

Citations

IDCFRDescription
14221 CFR 606.140(a)Establishment of spec., standards, and test procedures
7521 CFR 606.100(a)SOP compliance